Review Article
Urinary Markers of Glomerular Injury in Diabetic Nephropathy
Table 1
Overview of biomarkers of glomerular injury in diabetic nephropathy*.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DM1: studies in type 1 diabetic patients, DM2: studies in type 2 diabetic patients, MA: microalbuminuria, UAE: correlation with urine albumin excretion, CV: cardiovascular, IV-C: type IV collagen, GAGs: glycosaminoglycans, IgG: immunoglobulin G, L-PGDS: Lipocalin-type prostaglandin D2 synthase, IgM: immunoglobulin M. *: an empty space means not enough data published, **: presence prior to microalbuminuria, ***: predicts the development of microalbuminuria, “+/−”: conflicting results are published,: transferrin is correlated with cardiovascular risk, but albumin is a better predictor of ischemic heart disease. |